Answers are grounded in this paper and cite their sources.
Moderate-to-severe postoperative pain is commonly managed with opioids, but opioid-related adverse effects can limit their use. Tegileridine is a G protein-biased μ-opioid receptor agonist developed for acute postoperative pain. This structured narrative review summarizes its pharmacology and human clinical evidence, including studies published through 9 October 2026. We searched PubMed, Embase, the Cochrane Library, Web of Science, ClinicalTrials.gov , CNKI, and Wanfang from inception to 9 October 2026. Human studies of postoperative analgesia, perioperative procedural analgesia, pharmacokinetics, and drug interactions were considered; preclinical studies were used for mechanistic context. Tegileridine was superior to placebo in abdominal and orthopedic surgery trials, but its efficacy relative to established opioids remains unresolved. In the Phase III abdominal surgery trial, 24-h summed pain intensity difference (SPID24) values for tegileridine 1.0 mg and morphine were numerically close, with no formal non-inferiority or equivalence test reported. A 2026 meta-analysis found 24-h resting SPID significantly favoring morphine, while a 2026 single-center trial reported non-inferiority to sufentanil under its prespecified margin. Safety findings varied across trials. Nausea and vomiting did not differ significantly between tegileridine and morphine in the Phase III abdominal surgery trial, whereas lower rates were reported in several single-center studies. A small hysteroscopy dose-finding study also reported less respiratory depression or hypoxemia with tegileridine than with fentanyl; this exploratory finding requires confirmation. Most comparative studies remain small, single-center, or clinically heterogeneous. Further research is needed to clarify comparative efficacy, safety in specific populations, optimal dosing, and the clinical significance of pathway bias. Human abuse-liability and postmarketing safety data remain limited.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: